___ General Information Introduction to Diabetic Complications Canadian Diabetes Association Lipid Guidelines Sept 2006 2006 CDA Lipid Guidelines - Commentary [pdf] Canadian Lipid guidelines update [pdf] Diabetes and Dementia Glycemic Control & Dementia Statins Can Deteriorate Glycemic Control in Type 2 Diabetes Renin-Angiotensin System, Angiotensin II Receptor Blockade Less than 12% of Diabetics Meet Goals Diabetes in the Elderly: Special Considerations Insulin Resistance: the Problem Complications & Glucose Levels in Diabetes The Metabolic Syndrome & Prediabetes The Metabolic Syndrome, Does it Matter, Review 2007 [PDF] Perioperative Glycemic Control, CDA Recommendations Perioperative Management of Diabetes Dental Diseases and Diabetes Proposed Global Standardisation of HbA1c Measurement Ketone Testing Global Risk Management (.doc) ___ Diabetes in Pregnancy Gestational Diabetes: What is it? Gestational Diabetes Mellitus, What do you need to know? Does Gestational Diabetes Affect the Child? Diabetes and Pregnancy ___ Hypertension Hypertension in Diabetes / ARB treatment for patients with diabetes mellitus Treatment of Hypertension [pdf] ARB for Hypertension in Diabetics Guidelines and Goals in the Management of Hypertension Combination ACE & ARB Therapy Hypertension Direct Renin Inhibition: New Treatments for Hypertension ___Obesity Weight Management in Type 2 Diabetics Weight Control & Diabetes (.doc) CMAJ Obesity Guidelines 2007 [pdf] Management of Obesity in Diabetes Nutrition Therapy in Diabetes (.doc) ___ Dyslipidemia Canadian Diabetes Association Lipid Guidelines Sept 2006 Canadian Cardiovascular Society Lipid Guidelines 2009 Cholesterol and Blood Lipids Diabetic Dyslipidemia Statin Cost Efficacy [HTML] Statin Cost Efficacy [pdf] Anticoagulant & Inflammatory effect of Statins Lipoprotein Abnormalities in Type 2 Diabetes Effects of grapefruit juice on the toxicity of Statins in Clinical Practice Statin Risk Benefit Atorvastatin May Improve Endothelial Function ___Renal Complications Diabetic Nephropathy Combination ACE & ARB Therapy ACE & ARB in Diabetic Nephropathy ___Heart Disease Cardiovascular Risk Higher for Women Reducing cardiovascular events in diabetic patients Diabetic Youths Have Multiple Cardiovascular Risk Factors Thiazolidinediones: a Review of their Benefits and Risks in Type 2 Diabetes High Glucose Predicts Mortality in Heart Attacks ACE Inhibitors Improve Survival of Type 2 Patients Low-dose aspirin: Major benefits, minimal cost Restenosis after Coronary Stent Implantation in Patients with Type 2 Diabetes Post Prandial Glucose in Diabetes Peri-ACS Glycemic Control, CDA Recommendations Ramipril May Help Prevent Cardiovascular Events Intensive Glucose Control with IV Insulin in ICU [pdf] High Blood Glucose Boosts Short-Term Mortality in Heart Failure Patients Should all Diabetics take a Statin? Cardiovascular Risk Reduction 2009 (.doc) Cardiovascular Risk and Tight Glucose Control (Lessons from ACCORD & VADT 2009) ___ Neuropathy Erectile Dysfunction Classification of Diabetic Retinopathy Diabetic Retinopathy Painful Diabetic Neuropathy An Undisclosed Affair: Sexual Dysfunction In Diabetes Cannabinoid Spray (Sativex) Improves Neuropathic Pain ___ Diabetic Foot The Diabetic Foot ___Retinopathy Diabetic Retinopathy Classification of Diabetic Retinopathy